Our study demonstrated the SLE duration at conception, LN, history of therapeutic abortion, C3, lupus anticoagulant, IgG, serum ALB, CRP, PRO, HDL, and HCQ were identified as potential correlates of fetal loss in pregnant women with SLE with mild disease severity. Here, ALB is linked to systemic lupus erythematosus.